Atlas Trials

Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features

Clinical trial NCT01310140 · TERMINATED

Trial details

NCT number
NCT01310140
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Study type
OBSERVATIONAL
Major Depressive DisorderMajor Depressive Disorder w/ Psychotic FeaturesMetabolic Syndrome
Start date
2011-01-01
Primary completion
2012-09-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.